Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» rhabdomyosarcoma
rhabdomyosarcoma
FDA approves Immix Biopharma Rare Pediatric Disease Designation for cancer treatment
Biopharma Reporter
Tue, 01/4/22 - 10:48 am
Immix Bio
FDA
IMX-110
rhabdomyosarcoma
pediatric
Cellectar Granted Orphan Drug Designation for CLR 131 to Treat Rhabdomyosarcoma
CP Wire
Thu, 05/10/18 - 11:08 pm
Cellectar
FDA
orphan drug
CLR 131
rhabdomyosarcoma
Cellectar Granted Orphan Drug Designation for CLR 131 to Treat Rhabdomyosarcoma
Thu, 05/10/18 - 10:58 pm
Cellectar
CLR 131
rhabdomyosarcoma